- 1. Al element
- [extremely light, whitish, lustrous, metallic element, obtainable from bauxite or clay; atomic number, 13. ( CSP )] (UMLS (CSP) C0002367) =Element, Ion, or Isotope
| - 16. Aleukemic Leukemia
- [A leukemia characterised by the absence of leukemic cells in the peripheral blood. — 2003 ( NCI )] (UMLS (NCI) C0877858) =Neoplastic Process
|
- 2. Alemtuzumab
- [A monoclonal antibody used to treat leukemia. Monoclonal antibodies are made in the laboratory. They can find cancer cells and bind to them. Also called Campath-1H. ( NCI )] (UMLS (NCI) C0383429) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =[AN000] ANTINEOPLASTICS;
Unclassified Ingredients =ALEMTUZUMAB 10 MG/ML | - 17. Aleukemic Leukemia Cutis
- (UMLS (NCI) C0887846) =Neoplastic Process
|
- 3. Alemtuzumab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine
- (UMLS (NCI) C1328084) =Therapeutic or Preventive Procedure ;
| - 18. Aleukemic Lymphatic Leukemia
- (UMLS (NCI) C0334667) =Neoplastic Process
|
- 4. Alemtuzumab/Cyclophosphamide/Fludarabine
- (UMLS (NCI) C1134603) =Therapeutic or Preventive Procedure
| - 19. Aleukemic Lymphoblastic Leukemia
- (UMLS (NCI) C1332230) Aleukemic Precursor Lymphoblastic Leukemia;
=Neoplastic Process ;
|
- 5. Alemtuzumab/Fludarabine
- (UMLS (NCI) C1327792) =Therapeutic or Preventive Procedure ;
| - 20. Aleukemic Lymphoblastic Leukemia Cutis
- (UMLS (NCI) C1332231) Aleukemic Precursor Lymphoblastic Leukemia Cutis;
=Neoplastic Process ;
|
- 6. Alemtuzumab/Fludarabine/Melphalan
- (UMLS (NCI) C1134523) =Therapeutic or Preventive Procedure
| - 21. Aleukemic Monocytic Leukemia Cutis
- (UMLS (NCI) C1332232) =Neoplastic Process ;
|
- 7. ALENDRONATE SODIUM
- [A drug that affects bone metabolism. It is used in treating osteoporosis and Paget's disease, and is being studied in the treatment of hypercalcemia (abnormally high levels of calcium in the blood) and in treating and reducing the risk of bone pain caused by cancer. Alendronate sodium belongs to the family of drugs called bisphosphonates. ( NCI )] (UMLS (NCI) C0700482) =Organophosphorus Compound; Pharmacologic Substance
| - 22. Aleurain
- [This protein is a lysosomal cysteine proteinase important in the overall degradation of lysosomal proteins. It is composed of a dimer of disulfide-linked heavy and light chains, both produced from a single protein precursor. The protein, which belongs to the peptidase C1 protein family, can act both as an aminopeptidase and as an endopeptidase. Increased expression of this gene has been correlated with malignant progression of prostate tumors. (from LocusLink) ( NCI )] (UMLS (NCI) C0054869) =Amino Acid, Peptide, or Protein; Enzyme
|
- 8. Alendronate Sodium/Ketoconazole
- (UMLS (NCI) C0796551) KCZ/MK-217 =Therapeutic or Preventive Procedure
| - 23. Aleut
- (UMLS (HL7) C0574292) =Language =Aleut;
SirenikskiYupik;
EskimoAleut;
=Aleut |
- 9. Alendronic Acid
- [A second generation bisphosphonate and synthetic analog of pyrophosphate with anti-resorption activity. Alendronate sodium binds to and inhibits the activity of geranyltranstransferase (farnesyl pyrophosphate synthetase), an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which is important in the process of osteoclast turnover. As a result, bone resorption and turnover are reduced. ( NCI )] (UMLS (NCI) C0771311) =Organophosphorus Compound; Pharmacologic Substance
| - 24. Aleut
- (UMLS (NCI) C0085766) =Population Group ;
=Alaska Indian;
=Alutiiq Aleut;
Chugach Aleut;
Eyak;
Koniag Aleut;
Sugpiaq;
Suqpigaq;
Unangan Aleut;
Bristol Bay Aleut;
|
- 10. Alendros
- (UMLS (NCI) C1510842) =Organophosphorus Compound; Pharmacologic Substance
| - 25. Aleutian mink disease
- [A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible. ( MSH )] (UMLS (CSP) C0002016) =Disease or Syndrome
|
- 11. alentemol
- [ ] (UMLS (CSP) C0597883) =Pharmacologic Substance ;
| - 26. Aleutian mink disease parvovirus
- [A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color. ( MSH )] (UMLS (CSP) C0002017) =Virus
|
- 12. Alert Device Code
- (UMLS (HL7) C1547818) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Bracelet;
Necklace;
Wallet Card;
| - 27. Alexander technique
- [ ] (UMLS (CSP) C0597812) =Therapeutic or Preventive Procedure
|
- 13. Alert level
- (UMLS (HL7) C1547761) =Qualitative Concept =HL7 Vocabulary Version 2.5;
=Normal;
Warning;
Serious;
Critical;
| - 28. Alexander's disease
- [A rare inherited disorder of myelin formation. Alexander disease is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of cytoplasmic inclusions called Rosenthal fibers. The fibers contain GLIAL FIBRILLARY ACIDIC PROTEIN in association with ALPHA-CRYSTALLIN B CHAIN. Rosenthal fibers are found predominantly in ASTROCYTES located in the subependymal, subpial, and periventricular areas of the BRAIN. ( MSH )] (UMLS (CSP) C0270726) =Disease or Syndrome
|
- 14. alertness
- [ ] (UMLS (CSP) C1443086) =Mental Process ;
| - 29. ALEXIA
- (UMLS (ICD9CM) C0002018) =Disease or Syndrome
|
- 15. Alethine
- [A substance that is being studied as a treatment for cancer. It belongs to a family of chemicals called disulfides. ( NCI )] (UMLS (NCI) C0290021) =Organic Chemical; Pharmacologic Substance ;
| - 30. ALEXIA AND DYSLEXIA
- (UMLS (ICD9CM) C0002019) =Mental or Behavioral Dysfunction
|
home
